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Abstract
Rationale Nicotine has been shown to improve both
memory and attention when assessed through speeded
motor responses. Since very few studies have assessed
effects of nicotine on visual attention using measures that
are uncontaminated by motoric effects, nicotine’sa t t e n -
tional effects may, at least partially, be due to speeding
of motor function.
Objectives Using an unspeeded, accuracy-based test, the
CombiTVA paradigm, we examined whether nicotine
enhances attention when it is measured independently of
motor processing.
Methods We modelled data with a computational theory of
visual attention (TVA; Bundesen 1990) so as to derive
independent estimates of several distinct components of
attention from performance of the single task: threshold of
visual perception, perceptual processing speed, visual short-
term memory storage capacity and top–down controlled
selectivity. Acute effects of nicotine (2 mg gum) on
performance were assessed in 24 healthy young non-
smokers in a placebo-controlled counterbalanced, crossover
design. Chronic effects of nicotine were investigated in 24
age- and education-matched minimally deprived smokers.
Results Both an acute dose of nicotine in non-smokers and
chronic nicotine use in temporarily abstaining smokers
improved perceptual thresholds but slowed subsequent
perceptual speed. Moreover, both acute and chronic
nicotine use reduced attentional selectivity though visual
short-term memory capacity was unimpaired.
Conclusions Nicotine differentially affected discrete com-
ponents of visual attention, with acute and chronic doses
revealing identical patterns of performance. We challenge
prior reports of nicotine-induced speeding of information
processing by showing, for the first time, that nicotine
slows down perceptual processing speed when assessed
using accuracy-based measures of cognitive performance.
Keywords Nicotine.Attention.Cognition.Perceptual
processing speed.Selectivity.Memory.Smoker.
Non-smoker.Human
Introduction
In the last few decades, drugs targeting cholinergic function
have been suggested as therapeutic treatments for cognitive
dysfunction in neurodegenerative and neuropsychiatric
disorders, as well as potential cognitive enhancers in
normal subjects (Everitt and Robbins 1997; Ferrea and
Winterer 2009; Sarter and Parikh 2005). Nicotine acts as an
agonist at nicotinic acetylcholine receptors (nAChRs) in the
brain and modulates sensory responsiveness, psychomotor
function and information processing in both humans and
animals (Lawrence et al. 2002; Levin et al. 2006; Metherate
2004; Rezvani et al. 2002). Originally, cholinergic effects
on cognition were thought to pertain to learning and
memory, but this view was challenged by several experi-
ments showing that cholinergic effects on mnemonic or
learning processes vary as a function of attention (e.g.,
Rusted and Warburton 1992; for overviews, see Sarter et al.
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DOI 10.1007/s00213-011-2361-x2003; Coull 2005). Specifically, it has been suggested that
cholinergic activity in the brain is pivotal for certain aspects
of attention and only determines the efficacy of learning
and memory through its role in attentional processes (Sarter
et al. 2003; Sarter and Parikh 2005).
The majority of early human studies showing a
beneficial effect of nicotine on attention employed nicotinic
manipulations in smokers (Sherwood 1993). However, in a
review of 101 studies, Heishman et al. (1994) concluded
that nicotine reliably enhanced only a few cognitive
measures in non-smokers, among these finger tapping and
motor responding in tests of attention. Furthermore, they
concluded that both divided and selective attention are
generally much less susceptible to nicotinic influences than
tasks relying heavily on sustained attention. Sherwood
(1993) reached a similar conclusion in his review, suggest-
ing that nicotine may act as a mild CNS stimulant resulting
in reduction in the vigilance decrement and general
facilitation of motor responding, regardless of previous
smoking experience. The latter idea was recently supported
by a pharmaco-fMRI study (Rose et al. 2010) in which
nicotinic effects on measures of attention were mediated not
only by enhanced perceptual selectivity but also through
facilitation of motor readiness. Following this line of
reasoning, attentional effects ascribed to nicotine could in
part be due to alterations in motor readiness, as many
attentional tests employ motor-dependent response measures,
such as simple reactions times or speeded accuracy.
In a recent meta-analysis of over 40 studies, including
non-smokers and minimally deprived or non-deprived
smokers, Heishman et al. (2010) divided studies into
reaction time (RT) or accuracy-based outcomes and found
beneficial nicotinic modulation of simple motor perfor-
mance, alerting attention (accuracy and RT) and orienting
attention (only RT, not accuracy). Furthermore, their results
also reintroduced the possibility of a nicotinic involvement
in memory, considering that both short-term episodic
memory accuracy and working memory RT generally
improved with nicotine. However, the latter effect could
reflect a speed–accuracy trade-off, as five out of seven
working memory tests reporting both types of measures
showed a speeding of RTs accompanied by a decrease in
accuracy. Heishman et al. claimed that the beneficial
cognitive effects observed are likely to represent genuine
performance enhancement. Nevertheless, they argued that
to truly understand the effects of nicotine on human
cognition, studies are needed that assess several aspects of
human performance simultaneously and enable the model-
ling of complex performance in the laboratory. In parallel,
Vossel et al. (2011) have called attention to the lack of
studies comparing non-smokers and smokers, which are
necessary for clarifying the cognitive effects of acute and
chronic doses of nicotine, respectively.
Based on existing literature, we suggest that two
outstanding questions have yet to be answered. First, does
nicotine enhance the speed of attentional processing when
estimated independently of motor processing? Although the
effects of nicotine on speed-based measures of selective
attention, such as the Posner covert orienting of attention
task (e.g., Thiel and Fink 2008; Thiel et al. 2005), are
unlikely to be adequately explained by modulation of motor
processing, it is nevertheless necessary to test whether
nicotine can also be shown to affect attentional speed in an
entirely non-motor context. If so, we can more confidently
refute the claim that nicotine’s effects on RT-based
attentional tasks are mere consequences of more funda-
mental effects on motor processing. Second, we ask
whether nicotinic effects on discrete components of
attention, such as processing speed, selectivity or visual
short-term memory, can be dissociated when these are
measured simultaneously within the same experimental
paradigm? In addition, we use this opportunity to examine
whether the attentional performance of non-smokers in an
acute nicotinic challenge mimics the effects of chronic
nicotine in minimally deprived smokers.
The TVA (Bundesen 1990) provides an ideal framework
for investigating these questions. In contrast to most
computerised attention tests using RT measures, TVA-
based testing uses unspeeded, accuracy-based measures of
attention unconfounded by motor components. TVA-based
testing taps several attentional core functions such as how
much material can be stored in visual short-term memory
(VSTM) and how fast visual information can be processed.
Furthermore, with TVA-based testing, it is possible to
measure the threshold of conscious perception and the
selectivity of attention, as well as to characterise how
participants distribute their attention over space. In addi-
tion, in contrast to prior studies that have employed a
number of diverse tasks to examine effects of nicotine on
discrete components of attention, TVA allows for a more
streamlined approach in which a number of perceptual,
attentional and mnemonic measures are derived from
performance of a single task. Crucially, this approach
allows us to control for drug effects on potentially
confounding processes of non-interest, such as motor
responding or perceptual load, which, in traditional test
batteries, often vary widely between tasks.
TVA is a formal computational theory that describes
attention as a set of processes that allow us to select the
information that is currently relevant for behavior (for a
comprehensive account of these, see Bundesen 1990).
According to TVA, the selection process can be described
as a parallel processing race in which possible character-
isations of the objects in our visual field compete for access
to a VSTM with a limited capacity of K elements (one of
the basic parameters of the model). Only the winners of the
668 Psychopharmacology (2011) 218:667–680race that are selected and encoded into VSTM become
available for consciousness and action. However, the
chances of winning the race are not equal for all objects
and categories: In line with the ideas of Desimone and
Duncan (1995), the race is seen as a biased competition,
where not only the sensory evidence of certain categorisa-
tions but also attentional weights and subjective attentional
biases govern the probabilities of encoding certain objects
and categories. This encoding and selection process
proceeds in two stages: During the first stage, attentional
weights are calculated for every element in the visual field.
Basically, the weight reflects the strength of the sensory
evidence that the element is relevant. In the second stage,
the total processing capacity of the visual system is
distributed to the elements in proportion to their attentional
weights. The capacity allocated to a particular element
determines how fast this element is processed and, thus,
how likely it is to become encoded into VSTM. In TVA, the
total processing capacity of the visual system is assumed to
be a constant, independent of the number of elements in the
stimulus display (provided that the elements are homoge-
nous in the sense of Bundesen 1990, p. 524). The value of
this constant, C elements per second, is also a basic
parameter of the model.
TVA has successfully accounted for a wide range of
behavioural and neurophysiological attentional effects
(for an overview, see Bundesen and Habekost 2008).
As such, TVA provides a general theoretical framework
for investigating and explaining attention in normal
subjects (Finke et al. 2005;J e n s e ne ta l .2011)a n di n
patients (Bublak et al. 2005, 2006; Duncan et al. 1999;
Habekost and Rostrup 2006; 2007; Redel et al. 2011), as
well as for explaining the effects of psychopharmacological
manipulation (Finke et al. 2010).
Method
Participants
For the study 24 non-smoking participants (20 women,
four men, Mage=23 years, SD=2.3 years) and 24 regularly
smokingparticipants(17women,sevenmen,Mage=24.6 years,
SD=2.5 years) were recruited at the Faculty of Social
Sciences at the University of Copenhagen. To avoid
confounding effects from previous nicotine dependence in
the non-smoker group, we only recruited participants that
reported never to have been regular smokers nor smoked
within the last 2 years. Conversely, all participants in the
smoker group were required to have been smoking regularly
for at least the last 2 years. All participants but one (non-
smoker) were right-handed (Oldfield 1971), had normal
or corrected-to-normal vision and no prior history of
neurological or psychiatric disease. All participants
reported to be unmedicated except for contraceptives
and, in one case, insulin. We chose to include the data
from this non-smoking subject, as this did not change the
results. However, the results of two of the smokers are not
reported, as it turned out after testing that these participants
satisfied the exclusion criteria (specifically, colour blindness
and antidepressant medication).
Both participant groups were asked to abstain from
alcohol for at least 12 h before testing and from caffeine
for at least 3 h before testing. The non-smokers
participated in two sessions separated by 1 week (see
below) and received 80 Euros as a financial compensa-
tion for their involvement in the study. The smokers
were tested only once and received 40 Euros for their
participation. The study was carried out in accordance
with the ethical principles of the World Medical
Association (Declaration of Helsinki) and was approved
by the national ethical research committee (reference
number H-D-2008-092). Written informed consent was
obtained for all participants before entering the study.
Procedure
Drug administration and testing of non-smokers Drug
administration in the non-smokers was double-blinded,
randomised and counter-balanced. To enhance the sensitivity
of the study, we employed a within-subject design, and thus,
the non-smokers received either a single oral dose of nicotine
in a polacrilex gum (Nicotinell 2 mg, Novartis Healthcare A/
S) or a placebo gum with matched taste (Novartis Healthcare
A/S) in two separate sessions. Specifically, 12 participants
received placebo in their first session and nicotine in the
second, while the remaining participants received the
treatments in the reverse order. Sessions were separated
by at least 1 week to allow for complete wash-out of any
nicotine received in the first session. Participants were
instructed to chew the gum continuously for 1 min and
then let it rest for 2–3 min, repeated over 30 min during
which they remained seated in a designated waiting area.
Nicotine from nicotine gum is absorbed through the oral
mucosa throughout the period of chewing. During this
period, plasma nicotine concentrations increase slowly,
reaching a plateau after 30 min and then slowly decline
over the next 2 h (Benowitz et al. 1988). Choi et al.
(2003) investigated the pharmacokinetics of 2-mg nicotine
gum and found a maximal plasma concentration after
0.8 h (SD=0.2 h) and a half-life of 2.5 h (SD=1.2 h).
Even with considerable variability in individual pharma-
cokinetic responses, we assume that the non-smokers had
all reached their maximal plasma concentration after the
30-min pretest phase and showed only minor changes in
nicotine concentration during the 45-min test session.
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tive effects of nicotine, the non-smokers were asked to
complete a set of visual analog scales (VAS, see Bond and
Lader 1974) on three occasions during each session. The
VAS had the words “not at all” and “extremely” at each end
of a 10-cm line where participants were told to report their
answer to six different questions by marking a point on the
line corresponding to their subjective experience. Questions
were chosen to reflect effects of fatigue due to testing and
the most common complaints of adverse effects of nicotine
in non-smokers. The questions were: “How sleepy do you
feel right now?”, “How dizzy do you feel right now?”,
“How nauseous do you feel right now?”, “How blurred is
your vision right now?”, “How dry is your mouth right
now?” and “How alert do you feel right now?” The scales
were presented at baseline (just prior to drug administra-
tion), 30 min after drug administration (pretest) and 90 min
after drug administration (posttest).
Smoking history and behaviour Smokers were tested in one
session only and before completing the attention test (see
below), they answered three questions about their smoking
behaviour: “How many years have you been smoking?”,
“How many cigarettes do you smoke a day on average?”
and “How many hours is it since your last cigarette?” The
smokers had been informed that they were allowed to
smoke up to 2 h before the testing session but not during
the test. This procedure was chosen to avoid both
withdrawal effects and acute effects of nicotine.
Experimental paradigm
The CombiTVA paradigm was designed specifically for this
study as a combination of two classical experimental
paradigms: the whole report paradigm (Sperling 1960)
where all letter stimuli must be reported, and the partial
report paradigm (see Shibuya and Bundesen 1988) in which
only stimuli with a certain target feature (e.g. colour) are to
be reported. The CombiTVA test took 45 min to complete
and comprised 24 practice trials and nine experimental
blocks of 36 trials. All trials followed the same basic design
outlined in Fig. 1. A trial was initiated by a red fixation
cross in the middle of a black screen. This was succeeded
by a 100-ms blank screen before the stimulus display was
presented on an imaginary circle (r=7.5° of visual angle)
around the fixation cross with six possible stimulus
locations. After a variable stimulus duration, the letter
display was terminated by a 500-ms masking display
containing six masks made from red and blue letter
fragments. Then, the screen turned black, and the partici-
pant could type in the letters that he or she had seen. In
whole report trials, either two or six red target letters were
presented, while partial report trials featured two red target
letters and four blue distractor letters. Displays with six target
letters were shown for each of six stimulus durations (10, 20,
50, 80, 140 or 200 ms), while all other displays were shown
for 80 ms. All trial types were intermixed, and the stimuli in a
given trial were chosen randomly without replacement from a
set of 20 capital letters (ABDEFGHJKLMNOPRSTVXZ)
written in the font Ariel (broad) with a letter point size of 68
corresponding to 2.7°×2.3° of visual angle. The individual,
multicoloured masks were 100×100 pixels to completely
cover the letters.
Participants were instructed to make an unspeeded report
of all red letters they were “fairly certain” of having seen,
that is, to use all available information but refrain from pure
guessing. Participants were informed of the accuracy of
their reports (the probability that a reported letter was
correct) after each block, and they were encouraged to
report as many red letters as possible but keep their reports
within a specified accuracy range of 80–90% correct. The
stimulus displays were presented on a 19″ CRT monitor at
100 Hz using the E-prime 2 software. All tests were run in a
semidarkened room, with participants seated approximately
60 cm from the monitor.
Estimation of TVA parameters
The number of correctly reported letters in each trial
constituted the main dependent variable in the CombiTVA
test. The performance of the participants across the different
test conditions was modelled by TVA using a maximum
likelihoodfittingprocedure(fordetails,seeKyllingsbæk2006
and Dyrholm et al. 2011). Through this procedure, five
parameters quantifying attentional functions were estimated:
(1) K, the capacity of visual short term memory measured in
number of letters; (2) C, the speed of visual processing
measured in letters processed per second; (3) t0, the threshold
of conscious perception or the longest ineffective exposure
duration measured in seconds; (4) α, the top-down controlled
selectivity defined as the ratio between the attentional weight
of a distractor and the attentional weight of a target, so that α
values close to 0 indicate efficient selection of targets and
values close to 1 indicate no prioritising of targets compared
with distractors; and finally (5) windex, the spatial distribution
of attentional weighting defined as the ratio between the sum
of attentional weights assigned to elements in the left
hemifield and the sum of attentional weights across the entire
visual field in the partial report trials. In this laterality index,
windex, a value of 0.5 indicates unbiased spatial weighting of
attention, whereas values closer to 0 reflect a right-sided bias
and values approaching 1 reflect that more attentional
resources are used on the left side of the visual field.
The relationship between the first three parameters can be
visualised by plotting the mean number of letters correctly
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from the six-target whole report part of the CombiTVA
test. Figure 2, upper panel, shows the observed perfor-
mance of a single, representative subject and the predicted
performance following an exponential curve based on the
parameter estimates obtained through the TVA-based
fitting procedure. The subject does not report anything at
the shortest stimulus duration of 10 ms, but the mean
Fig. 1 Outline of a single trial
in the CombiTVA paradigm
showing timing and three types
of letter displays used: six target
whole report (red letters), two
target whole report (red letters),
and two target and four distrac-
tor partial report (red and blue
letters)
Fig. 2 Upper panel Whole re-
port performance of a represen-
tative non-smoker in the placebo
condition (PLA) showing the
mean number of correctly
reported letters as a function of
exposure duration. The solid
curve represents a TVA-based fit
to the observations. The esti-
mated visual short-term memory
capacity, K, is the horizontal
asymptote of the fitted curve. t0
is the longest ineffective expo-
sure duration, the point at which
the curve rises from the abscis-
sa. The slope of the curve at t0
corresponds to the perceptual
processing speed, C. Lower
panel Nicotine induced changes
in whole report performance
showing observed and estimated
performance following placebo
(PLA, diamonds and solid line)
and observed and estimated
performance following nicotine
(NIC, dots and dashed line)
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following durations and levels off at approximately 3.5
letters at the longer exposures. The point at which the
curve rises from the abscissa represents the t0 value: At
exposures briefer than t0, nothing can be reported. The
s l o p eo ft h ec u r v ea tt0 represents the C value: The steeper
the slope, the more letters can be processed per second.
Finally, the horizontal asymptote of the curve is the
maximum number of items that can be retained in visual
short-term memory: the K value.
The efficiency of top–down selection, represented by the
α value, is estimated by comparing performance in the
partial report trials (two targets and four distractors
presented simultaneously) with performance in the whole
report trials (two targets presented alone). A participant
with perfect selection should be unaffected by the presence
of distractors and thus report the same number of targets
regardless of the number of distractors.
Results
Statistical analyses were carried out using PASW
statistics version 18. For all analyses, differences were
considered to be statistically significant at the 0.05 level.
Effect measures for t tests and analyses of variance are
stated as h2
p and Cohen’s d, respectively. For repeated
measures, the d value was corrected for correlations
between samples (see Dunlap et al. 1996). Finally, several
of the attentional parameters measured here have been
shown to be negatively affected by age; therefore,
interparameter correlations were calculated as partial
correlations assuming a linear effect of age (Field 2009).
This did not change the conclusions in any way.
Attention in non-smokers and smokers
The parameter estimates obtained through the TVA-based
fitting procedure correspond to values previously found in
groups with comparable age and education (Jensen et al.
2011). The mean values for each of the three groups (non-
smokers in placebo and nicotine conditions, and smokers)
are summarised in Table 1. On average, the smokers had
the lowest threshold of conscious perception, t0, followed
by non-smokers under nicotine and non-smokers under
placebo. Conversely, the fastest mean processing speed, C,
was observed in non-smokers under placebo, followed by
non-smokers under nicotine and finally smokers. The same
pattern was repeated for selectivity, where non-smokers
under placebo were the most selective and smokers the
most distractible. There was, however, large variation in all
three groups. The mean capacity of visual short term
memory, K, was nearly identical in all groups, as was the
spatial distribution of attention (as measured by windex). The
non-smokers in the placebo condition did show a small
rightward bias in spatial attention, but even though the
laterality index approached a significant deviation from the
optimum value of 0.5, the size of this effect was only
moderate, t(23)=−2.02, p=0.06, d=0.58. Attentional
weighting of the smokers and non-smokers under nicotine
did not deviate from the unbiased windex of 0.5, both ts<1.
The error proneness of participants was estimated as the
probability that a reported letter was incorrect (i.e. a distractor
ora letternot includedin the display). On average, 18% of the
reports made by non-smokers in the placebo condition were
erroneous, rising to 20% in the nicotine condition. Non-
smokers were therefore within the instructed accuracy range
(80–90% correct reports). By contrast, 24% of the letters
reported by the smokers were erroneous, meaning that they
were actually less accurate than instructed.
The two capacity parameters, C and K, have previously
been shown to be moderately positively correlated in
normal samples, reflecting a tendency for faster processing
in subjects with large capacities of visual short-term
memory (Finke et al. 2005). Our findings replicated this
relationship in all three conditions: non-smokers under
placebo, r(21)=0.68, p<0.001; non-smokers under nico-
tine, r(21)=0.58, p=0.004; and smokers, r(19)=0.57, p=
0.007, all corrected for age. No other inter-parameter
correlations were significant for the non-smokers in either
condition (all ps>0.12), whereas the perceptual threshold of
the smokers was lowered as their average error rate
increased, r(19)=−0.62, p=0.003, corrected for age.
Nicotine-induced attentional change in non-smokers
We analysed nicotine-induced changes in non-smokers by
comparing placebo and nicotine sessions in mixed
Table 1 Attentional performance of non-smokers and smokers
Parameter Non-smokers Smokers
Placebo Nicotine
M (SD) M (SD) M (SD)
t0 15 (8) 12 (8) 10 (9)
C 70 (24) 55 (23) 51 (18)
K 3.30 (0.50) 3.20 (0.60) 3.20 (0.70)
α 0.53 (0.26) 0.64 (0.37) 0.68 (0.27)
windex 0.47 (0.08) 0.50 (0.08) 0.49 (0.09)
Error rate 0.18 (0.05) 0.20 (0.07) 0.24 (0.09)
Units for the individual parameters are t0 (ms), C (letters/second), K
(letters), α ranges from perfect selection at 0 to non-selectivity at 1,
windex ranges from complete rightward bias at 0 to complete leftward
bias at 1 with 0.5 indicating equal weighting between the two visual
fields
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factor and drug order (nicotine-placebo, placebo-nicotine)
as a between subjects factor. Nicotine significantly im-
proved the threshold of conscious perception by lowering
t0, F(1, 22)=4.83, p=0.04, h2
p=0.18, thus advancing the
point in time at which stimulus encoding began (Fig. 3,
upper right panel). However, nicotine also severely slowed
down subsequent visual processing speed, C, F(1, 22)=
31.42, p<0.001, h2
p=0.59 (Fig. 3, upper left panel), and also
compromised visual top-down selectivity, α, F(1, 22)=7.01,
p=0.02, h2
p=0.24 (Fig. 3, lower left panel). The capacity of
visual short term memory, K, was unaffected by the nicotinic
challenge, F(1, 22)=1.57, p=0.22, h2
p=0.07 (Fig. 3,l o w e r
right panel). Figure 2, lower panel, illustrates nicotinic
effects on the t0, C and K parameters derived from whole
report performance for a single representative non-smoker.
Nicotine also resulted in a small but significant leftward shift
in spatial bias, windex, F(1, 22)=9.56, p=0.01, h2
p=0.30 and
made subjects more error prone, F(1, 22)=5.50, p=0.03,
h2
p=0.20. Importantly, the order of the sessions in which
the participants received placebo and nicotine did not
affect any of the measures, as all main effects of drug
order and interactions between drug and drug order were
non-significant, all Fs<1.45, all ps>0.24.
The correlations between nicotine and placebo conditions
were moderate to large for all parameters and highly
significant; thus, the reported changes appear to be very
systematic: K, r(21)=0.75, p<0.001; C, r(21)=0.84, p<
0.001; t0, r(21)=0.57, p<0.01; α, r(21)=0.81, p<0.001;
windex, r(21)=0.77, p<0.001; error rate, r(21)=0.64, p=
0.001, all corrected for age.
The possibility exists that the increased error proneness
observed after nicotine could somehow have influenced the
estimates for the attentional parameters affected by nicotine.
To control for this, we calculated the difference scores (i.e.
score in placebo condition minus score in nicotine
Fig. 3 Mean TVA parameter
estimates for smokers and for
non-smokers following placebo
and nicotine, respectively. Pan-
els represent performance on
four basic components of visual
attention. Upper left panel C,
the speed of visual processing;
upper right panel, t0, the
threshold of conscious percep-
tion; Lower left panel α, the
top–down controlled selectivity
where α values close to 0 reflect
efficient selection and values
close to 1 reflect non-selectivity;
lower right panel K, the capac-
ity of visual short term memory.
Differences between the groups
are indicated by p values. Error
bars show standard errors of the
means
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difference score for the error rate. Correlations between
error rate and TVA parameters were, on average, 0.13
(range, 0.01–0.28), and none were significant. Therefore,
changes in error rate did not seem to influence nicotinic
effects on attention parameters.
Finally, to investigate whether baseline performance was
influencing the drug induced changes observed, we divided
participants into two groups based on their placebo score (i.
e. above or below the median placebo score) and used the
resulting binary variable as a between subjects factor in a
mixed measures ANOVA with drug (nicotine and placebo)
as within subjects factor. We repeated this procedure for all
five TVA-based parameters and found that none of the
resulting interaction effects between drug and placebo score
group were significant: K, F(1, 22)=3.56, p=0.07, h2
p=
0.15; C, F(1, 22)=2.04, p=0.17, h2
p=0.09; t0, F(1, 22)=
2.28, p=0.15, h2
p=0.09; α, F(1, 22)=0.03, p=0.87, h2
p=
0.001; windex, F(1, 22)=1.02, p=0.32, h2
p=0.05.
Subjective measures in non-smokers
As expected, none of the VAS measures differed signifi-
cantly between the placebo and nicotine conditions at
baseline (all ps>0.16 in paired t tests), whereas several
significant differences were found at pretest and posttest
(see Fig. 4). The effects of nicotine and time-on-task were
assessed in 2×3×2 mixed measures ANOVAs with drug
(nicotine and placebo) and time (baseline, pretest and
posttest) as within subjects factors and drug order (nico-
tine–placebo and placebo–nicotine) as between subjects
factor. All measures but the blurred vision measure were
negatively affected by nicotine: sleepiness, F(1, 18)=
6.82, p=0.02, h2
p=0.28; dizziness, F(1, 18)=13.33, p=
0.002; h2
p=0.43; nausea, F(1, 18)=5.41, p=0.03, h2
p=0.23;
dry mouth, F(1, 18)=5.08, p=0.04, h2
p=0.22; alertness, F
(1, 18)=6.30, p=0.02, h2
p=0.26. This pattern repeated for
the main effects of time where all measures but dry mouth
were negatively affected by time-on-task: sleepiness, F
(1.31, 23.58)=10.59, p=0.002, h2
p=0.37; dizziness, F
(1.28, 23.03)=14.11, p<0.001, h2
p=0.44; nausea, F(2,
36)=4.29, p=0.02, h2
p=0.19; blurred vision, F(1.36,
24.38)=6.16, p=0.01, h2
p=0.26; alertness, F(1.27, 23.16)=
10.45, p=0.002, h2
p=0.37. The non-integer degrees of
freedom reflect Greenhouse–Geisser corrections due to
violations of assumed sphericity in the time factor. The
effect of testing time was mainly driven by the changes from
baseline in the nicotine condition (cf. Fig. 4), resulting in
significant drug×time interactions for experience of
dizziness [F(2, 36)=14.25, p<0.001, h2
p=0.44],drymouth
[F(2, 36)=8.58, p=0.001, h2
p=0.33] and alertness [F(2,
36)=3.30, p=0.048, h2
p= 0 . 1 6 ] .F u r t h e r m o r e ,t h e r ew a sa
marginally significant interaction effect for nausea [F(2,
36)=3.27, p=0.05, h2
p=0.15], but none for sleepiness or
blurred vision (both ps>0.14). Again, the order in which
the participants received the drugs did not affect any of the
measures, all Fs<2.17, all ps>0.16.
The relationship between the objective effects of nicotine
and the participants’ subjective experience of nicotine was
explored by comparing the difference scores for the TVA
parameters with difference scores for the VAS measures
(placebo minus nicotine) at pretest and posttest, respective-
ly. Despite the significant effects of nicotine on the
subjective measures, they did not significantly correlate
with the TVA parameters, at neither pre- nor posttest
(average correlation=0.14; range, 0.001–0.40).
Fig. 4 Mean subjective effects of an acute dose of nicotine (triangles)
or placebo (circles) in non-smokers. Data were collected using visual
analog scales at baseline (just prior to drug administration), pretest
(30 min after drug administration), and posttest (90 min after drug
administration). Statistically significant differences between drug
conditions are indicated for *p<0.05 and **p<0.01. Error bars show
standard errors of the means
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On average, the participants reported to have been smoking
for 8.7 years (SD=3.25 years) and to smoke on average
12.7 (SD=6.61) cigarettes a day. The median number of
hours since their last cigarette at the time of testing was
2.75. One participant had not smoked for 72 h before
testing, but the range for the remaining participants was 2–
15 h. As the performance of the aforementioned participant
did not deviate significantly from the rest of the subject
group, her results were included in all analyses. As we
expected, correlations showed that older participants had
been smoking for more years, r(20)=0.65, p=0.001, and
that participants who smoked fewer cigarettes per day had
been abstinent for more hours before the test, r(20)=0.46,
p=0.03. However, smoking behaviour was not correlated
with any of the attentional parameters.
Attention in non-smokers versus smokers
The similarity of the smokers’ performance to the non-
smokers under placebo and nicotine, respectively, was
investigated in planned, independent t tests with group
(smoker/non-smoker) as a between-subjects factor. Compared
tothe non-smokers atplacebo,the smokers hada significantly
lower perceptual threshold, t(44)=2.27, p=0.03, d=0.48
(Fig. 3, upper right panel), and they showed a marked
slowing of processing speed, t(44)=3.14, p=0.003, d=0.67
(Fig. 3, upper left panel). Similarly, the smokers made more
errors, t(30.90)=−2.67, p=0.01, d=−0.57 (degrees of free-
dom corrected for unequal variances), and had a marginally
significantly compromised selectivity, t(44)=−1.92, p=0.06,
d=−0.41 (Fig. 3, lower left panel). Finally, neither the
capacity of short term memory (Fig. 3, lower right panel) nor
the spatial distribution of attention in the smokers were
different from the non-smokers under placebo, both ts<1,
both ds<0.16. By contrast, the performance of smokers was
not significantly different from performance of non-smokers
under nicotine, for any of the attentional parameters, all ts<1,
all ds<0.20 (Fig. 3). This was also the case when comparing
the error rates, t(44)=2.16, p=0.15, d=−0.31.
Discussion
In our study of cholinergic modulation of visual attention,
we challenge the notion of the cholinergic agonist nicotine
as a performance-enhancing drug. We examined the effects
of both acute and chronic nicotine on visual attention using
the new CombiTVA paradigm, which was designed to
assess distinct components of visual attention within a
single task. Acute nicotine administration in non-smokers
resulted in a lower perceptual threshold, thus advancing the
point in time at which encoding of information into visual
short-term memory was begun. However, nicotine induced
tradeoffs by slowing down subsequent information process-
ing and weakening attentional selectivity, reflecting the fact
that subjects were more prone to spend valuable resources
on irrelevant information. Finally, nicotine had no effect on
the capacity of visual short-term memory. Although
nicotine increased subjective feelings of nausea, dizzi-
ness and dry mouth as well as decreasing alertness, these
effects did not correlate with nicotine’se f f e c t so n
attentional performance. Consequently, the attentional
effects were not driven by a lack of nicotine tolerance.
The effects of chronic nicotine were characterised by
comparing an age and education matched group of
minimally deprived smokers to the non-smokers. Interesting-
ly, the pattern of performance in the smokers closely matched
the performance shown by non-smokers after an acute dose of
nicotine: as compared to non-smokers receiving placebo,
smokers also showed an earlier perceptual threshold,
slower encoding into visual short-term memory and
compromised selectivity.
Nicotine improves the perceptual threshold but slows
subsequent perceptual processing speed
In our study, nicotine allowed stimuli to be perceived at
significantly shorter exposure times, thereby lowering the
perceptual threshold, t0. Beneficial effects of nicotine on
low-level perceptual processes have previously been found
using both motor measures of performance, such as visual
pop-out reaction time (Rycroft et al. 2005), or more
perceptual measures, such as the critical flicker fusion
threshold (Sherwood 1993). Similarly, another measure of
perceptual sensitivity, the d′ parameter, estimated through
analyses of hits and false alarm rates by signal detection
theory (Green and Swets 1966), has been shown to be
enhanced by nicotine in near-threshold detection paradigms
(Jones et al. 1992; Rezvani et al. 2002; Wesnes et al. 1983).
Finally, several studies employing another accuracy-based
paradigm, the visual inspection time (IT) task have shown
beneficial effects of nicotine. IT is defined as the minimum
stimulus exposure time required to reach near-perfect
response accuracy in a simple two-choice visual discrimi-
nation and is argued to reflect stimulus input stages of
visual perception (Stough et al. 1995). In abstaining (2–
10 h) smokers, nicotine improved early perception by
lowering IT (Thompson et al. 2002), while the nicotinic
antagonist mecamylamine prolonged IT in non-smokers
(Thompson et al. 2000). This was proposed to be the result
of a nicotinic improvement in perceptual processing speed.
However, the IT procedure does not allow for separation of
perceptual threshold from processing speed, which is a
major strength of our CombiTVA paradigm. Our own
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caused by nicotinic improvements in perceptual threshold,
rather than processing speed per se. Taken as a whole,
observations of lowered perceptual thresholds and improved
perceptual sensitivity converge to support the notion that
nicotine may enhance sensory responsiveness in the cortex
(Metherate 2004;S a r t e re ta l .2005).
In contrast to the beneficial effects of nicotine on the
perceptual threshold, both acute and chronic doses of
nicotine slowed down visual information processing speed.
However, the most well-established finding in the literature
on effects of nicotine is a speeding of motor response time
(Heishman et al. 1994, 2010; Sherwood 1993). Faster
motor responses may not only reflect true enhancement of
information processing but may also reflect speed–accuracy
trade-off or purely motoric effects. Not all RT-based studies
report accuracy outcomes but in the ones that do, faster RTs
are often coupled with negative or null effects on accuracy
(e.g. Thiel and Fink 2008). Correspondingly, in their recent
meta-analysis Heishman et al. (2010) concluded that the
enhancing effects of nicotine could be mediated through
facilitation of motor processes. This view is supported by
the neurobiology of the nicotinic system. Nicotinic recep-
tors (nAChRs) play a substantial role in modulating
synaptic transmission in several subcortical and cortical
areas, including the striatum and parts of the motor cortex
that are crucial for efficiency of motor responses (Feldman
et al. 1997). In addition to the physiological effects on the
CNS that presumably underlie changes in cognitive
processes, nicotine also has peripheral physiological effects.
In the doses normally applied in human studies, nicotine
has an excitatory effect upon the nicotine cholinergic
receptors at neuromuscular junctions (Feldman et al.
1997), and this could accentuate the possible central motor
facilitation caused by nicotine. As our experiments did not
include RT-based measures, we cannot determine whether
our findings are part of a speed–accuracy trade-off induced
by nicotine. However, this seems implausible given that
subjects were explicitly instructed to give unspeeded
reports. Rather, our results show that nicotinic effects on
information processing speed are not exclusively beneficial.
Thus, although numerous studies have previously found
that nicotine enhances motor speed, we show for the first
time that it slows down perceptual processing speed.
Nicotine impairs top–down attentional selectivity
We found that both acute and chronic nicotine impaired
attentional selectivity. Nicotine effects on measures of
selective attention are notoriously variable, with some
studies reporting improvement while others show no effect
(see Heishman et al. 1994, 2010 for reviews). Since many
of the studies reporting beneficial effects of nicotine
employed reaction time measures, Heishman et al. (2010)
suggested that nicotine’s effects on selectivity may in fact
derive from motoric effects. In the present study, we have
found that if attentional selectivity is measured with
accuracy scores, nicotine actually impairs selectivity.
One of the tasks most commonly used to index selective
attention is the spatial orienting paradigm (Posner et al.
1980), in which an initial cue directs attention to a spatial
location in which a subsequent target may (valid trial), or
may not (invalid trial), appear. The validity effect measures
the behavioural cost (indexed by slowed reaction times) of
detecting targets that appear in the non-cued location.
Nicotine has consistently been found to reduce the validity
effect, primarily by speeding responses to invalidly cued
targets (Meinke et al. 2006; Phillips et al. 2000; Thiel and
Fink 2008; Thiel et al. 2005; Vossel et al. 2008, 2011; Witte
et al. 1997). Yu and Dayan (2005) suggested that the
reduced validity effect after nicotine might reflect a less
efficient use of the spatial information carried by the cue.
This mechanism is entirely consistent with our own finding
that nicotine impairs attentional selectivity: Nicotine-
induced reduction in selectivity would result in a reduced
reliance on the cue, and, consequently, invalidly cued
targets would be processed more quickly following nicotine
than following placebo.
Being less selective and more distractible may, however,
in some cases confer a behavioural advantage. As previ-
ously discussed, performance in a cueing experiment, in
which not being misled by invalid cues is important, might
in fact benefit from a less focused use of the information
provided by the cues. Likewise, being more distractible
may also aid performance in prospective memory tasks,
where participants are required to switch attention away
from an attention demanding ongoing task in order to
register and respond to an infrequently occurring prospec-
tive memory cue (Rusted et al. 2009; Rusted and Trawley
2006). Finally, there is evidence that the attentional blink, a
transient impairment in the ability to report the second of
two targets presented in close temporal succession, is
attenuated if participants are actively required to distract
their attention from the task at hand (see, e.g. Olivers and
Nieuwenhuis 2006).
Nicotine has no effect on VSTM capacity
In our terminology, parameter K is the storage capacity of
VSTM, and VSTM can be considered synonymous with
visual working memory, WM (cf. Baddeley 1999). The lack
of nicotinic effect on K fits well with the conclusions of a
recent meta-analysis (Heishman et al. 2010) in which RT-
based measures of WM were concluded to benefit from
nicotine, whereas WM assessed through accuracy scores
showed no significant change after nicotine. The null effect
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(Ernst et al. 2001; Heishman and Henningfield 2000;
Kleykamp et al. 2005; Myers et al. 2008) is supported by
investigations demonstrating that WM and visuospatial
attention performance have different genetic underpinnings
(Greenwood et al. 2005; Parasuraman et al. 2005). Here
attention—but not WM—was shown to be modulated by
changes in a polymorphism on a gene crucial for one of the
nAChRs. Conversely, the ability to retain several locations
in WM—but not visuospatial attention—interacted with
variation in a polymorphism on a gene involved in the
conversion of dopamine to noradrenaline. Correspondingly,
in a recent TVA-based study, modafinil, an analeptic drug
increasing the release of dopamine and noradrenaline, was
found to enhance visual short-term memory in low-
performing subjects (Finke et al. 2010). Thus, the WM
aspect of human memory does not seem to depend on
cholinergic nicotinic involvement, although prospective
memory, the memory for an intention to perform a specific
act, may do so (Heishman et al. 2010; Rusted et al. 2009;
Rusted and Trawley 2006).
Acute versus chronic effects of nicotine
Using accuracy-based measures of attentional performance,
we have found nicotine-induced impairments in the speed
and selectivity of attentional operations. However, some
prior studies have reported beneficial effects of nicotine,
even when accuracy-based measures are used (Hahn et al.
2007; Jones et al. 1992; Lawrence et al. 2002). A possible
interpretation of the discrepant findings was put forth by
Newhouse et al. (2004), who pointed to differences in the
populations represented in studies on nicotine: Studies
showing null-effects or impairment after nicotine generally
use non-smoking subjects, while studies using abstaining
smokers or clinical populations tend to argue in favour of a
beneficial effect of an acute dose of nicotine.
In our own study, we examined both acute attentional
effects of nicotine in non-smokers and chronic attentional
effects of nicotine in minimally deprived smokers, and
found no difference between these effects. Importantly, we
did not find any correlation between the smoking behaviour
and history of the smokers and their attentional performance,
even though the number of hours that the smokers had been
abstaining could be expected to impact negatively upon
performance. Comparisons of smokers to non-smokers in
the absence ofanacutenicotinechallenge are relativelyscarce
(Vosseletal.2011), but those that do exist demonstrate either
impaired attentional performance for even mildly abstinent
smokers (Foulds et al. 1996; Lawrence et al. 2002; Vossel et
al. 2011) or else no difference between smokers and non-
smokers (Hahn et al. 2007, 2009; Rusted and Trawley 2006).
Therefore, the acute and chronic effects of nicotine in
smokers appear to counterbalance one another, which is of
course consistent with the notion that acute nicotine in
smokers serves to return the system to its “normal”
functioning state. If attentional performance is related to
nicotinic stimulation in a curvilinear relationship (i.e. as
described by Yerkes and Dodson 1908), only an intermediate
level of stimulation yields optimal performance, whereas low
or high levels of stimulation will lead to impaired
performance. As a consequence, for a normal non-
smoking individual performing optimally at baseline,
acute nicotinic stimulation could have deleterious effects.
Conversely, in both abstinent smokers and patients with
reduced cholinergic tone due to neurocognitive disease
who can be assumed to perform suboptimally at baseline,
the same nicotinic stimulation could significantly enhance
cognitive performance. In line with this, it has been suggested
that the immediate relief from withdrawal symptoms offered
byacuteadministrationofnicotineinsmokers orpatientswith
a nicotine deficit plays a crucial role in nicotine addiction in
those groups (Benowitz 2008).
One limitation of this study is that we did not examine
the effects of an acute dose of nicotine in abstaining
smokers. According to the observation of Newhouse et al.,
this should result in improvements in perceptual processing
speed and selectivity, which would lie in contrast to the
equivalent impairments we observed in non-smokers.
Future studies will test this hypothesis using a placebo-
controlled cross-over design to examine attentional effects
in smokers, using different doses of nicotine in order to
characterise a possible dose-dependent relationship between
nicotinic stimulation and values of TVA-based attentional
parameters. Furthermore, in order to further investigate the
proposed dissociation between nicotinic effects on motor
and perceptual processing speed, RT-based measures will
be included in addition to purely accuracy-based measures.
Explaining nicotine effects with a theory of visual attention
The current neural interpretation of TVA (NTVA; Bundesen
et al. 2005) does not account for the neurochemical basis of
visual selection and recognition, but the theory does
suggest some plausible neuroanatomical substrates for these
processes. Specifically, the attentional weights computed
for each stimulus object in the visual field are tentatively
proposed to be stored in a saliency map in the pulvinar
nucleus of the thalamus. Cortical processing capacity is
then redistributed according to attentional weight signals
from the pulvinar nucleus to the cortex, such that objects
with high attentional weights are processed by more
neurons than objects with low attentional weights. The
encoding speed of an object is proportional not only to the
number of neurons allocated to its processing but also to the
level of activation of these neurons, which is governed by
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within the visual system but derive from signals originating
in frontal and parietal cortical areas.
The overall pattern of our findings may be explained
in terms of NTVA by making two assumptions
concerning the effects of nicotine. The first assumption
is that nicotine truncated the computation of attentional
weights, making it prompt but inaccurate. In TVA, t0 is
the longest ineffective exposure duration (see Fig. 2,
upper panel), and this threshold depends on the time
taken to compute attentional weights for objects pre-
sented in the visual field. Specifically, fast computations
lead to lower temporal thresholds but imprecise weights,
whereas elaborate computations result in higher temporal
thresholds and more accurate weights. Visual selectivity,
α (the ratio between the attentional weight of a distractor
and the attentional weight of a target), depends critically
on the precision of attentional weight estimates. Conse-
quently, less accurate attentional weights result in an
increment in the selectivity parameter, α, indicating that
valuable attentional resources are spent on irrelevant
information. As touched upon previously with reference
to spatial orienting paradigms, unfocused selectivity
would result in differential speeding of processing invalid
targets, whereas focused selectivity would favour process-
ing of valid targets.
The second assumption is that nicotine caused a decrease
in subjective biases for task-relevant (letter) categorisations,
resulting in less efficient encoding of the letters into VSTM,
evident in the slowing of the processing speed parameter,
C. Note that although encoding of letters into VSTM
should be slowed down, the number of items that can be
stored in VSTM, K, should not be affected.
Support for these assumptions concerning nicotinic
effects on attentional weights and perceptual biases comes
from different areas of neuroscience. First, the pulvinar
nucleus, which is likely to be critical for computing
attentional weights, contains an abundance of presynaptic
nicotinic receptors and receives substantial cholinergic
projections from the pedunculopontine nucleus (Spurden
et al. 1997). These projections are part of the reticular-
activating system and probably play an important role in
arousal and visual attention alike (Coull 1998). Second,
Metherate (2004) reviewed the function of the nicotinic
receptors (nAChRs) in the CNS and found an emerging
consensus that cortical nAChRs likely act to change
sensory responsiveness, which may contribute to improved
behavioural performance in cognitive tasks. Metherate
suggested that this is achieved by nicotinic regulation of
glutamatergic and GABAergic activity in the thalamus,
resulting in alterations in thalamo-cortical neurotransmis-
sion. Interestingly, Petersen et al. (1987) demonstrated the
involvement of GABAergic activity in the pulvinar in a
spatial cueing paradigm by injecting GABAergic drugs into
parts of the pulvinar nuclei of rhesus monkeys. The
procedure manipulated attentional performance in such a
way that attentional shifts from one visual field to the other
depended on the level of GABAergic activation in the
contralateral pulvinar. Several researchers have interpreted
this as support for the hypothesis that the pulvinar is crucial
for the representation of attentional weights (Bundesen et
al. 2005; Desimone and Duncan 1995). Finally, neuro-
imaging studies in humans have observed that thalamic and
parietal regions are among the areas most consistently
modulated by cholinergic or, more specifically, nicotinic,
manipulations. Using PET, Mentis et al. (2001) found that
nicotine specifically modulated activity in the thalamus and
inferior parietal cortex, and this finding has been replicated
many times since in pharmaco-fMRI studies, which show
that nicotine (or acetylcholine in general) increases
attention-related activity primarily in the pulvinar nucleus
of the thalamus and in parietal cortex (Bentley et al. 2004;
Hahn et al. 2007, 2009; Lawrence et al. 2002; Thiel et al.
2005 ). In summary, in an interpretation drawing upon
NTVA and evidence from different areas of neuroscience,
nicotinic modulation of thalamic areas might result in
quickly computed but inaccurate attentional weights,
whereas nicotinic modulation of parietal cortex might result
in abnormal perceptual biases.
Conclusion
Both an acute dose of nicotine in non-smokers and
chronic nicotine use in temporarily abstaining smokers
diminishes perceptual thresholds while simultaneously
slowing perceptual speed. In addition, both acute and
chronic nicotine use reduce attentional selectivity but
leaves short-term memory capacity unimpaired. Crucially, the
nicotine-induced slowing in perceptual processes stands in
contrast to prior reports of nicotine-induced speeding of
motor processes.
Our results also serve to accentuate the utility of
employing accuracy-based measures of cognitive perfor-
mance in psychopharmacological studies, not least when
investigating the effects of neurochemical substances that
may also influence basic motor function. Moreover,
using TVA to derive discrete measures of perceptual,
attentional and mnemonic performance from the same,
single task we could control for drug effects on
potentially confounding processes of non-interest, such
as perceptual load or motor function. Finally, the
specificity of our TVA results attests to the use of
TVA-based measures for psychopharmacological re-
search, in which highly specific and sensitive measures
of discrete components of attention are imperative.
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